SLC22A3 and colorectal carcinoma: Baseline SLC22A3 mRNA expression was lowest in HCT116 cells among the three CRC cell lines, and the mRNA expression levels of SLC22A3 were significantly higher in HT29 and SW620 cells (P<0.05, Fig. 2A).